{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T13:42:51Z","timestamp":1773754971706,"version":"3.50.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/mpa.0b013e318287c9b5","type":"journal-article","created":{"date-parts":[[2013,6,15]],"date-time":"2013-06-15T11:06:28Z","timestamp":1371294388000},"page":"786-794","source":"Crossref","is-referenced-by-count":6,"title":["The Effects of Dipeptidyl-Peptidase-IV Inhibitor, Vildagliptin, on the Exocrine Pancreas in Spontaneously Diabetic Goto-Kakizaki Rats"],"prefix":"10.1097","volume":"42","author":[{"given":"Hiroki","family":"Mizukami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soroku","family":"Yagihashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210212","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2337\/diab.31.10.883","article-title":"New perspective on the microvasculature of the islet of Langerhans in the rat.","volume":"31","author":"Bonner-Weir","year":"1982","journal-title":"Diabetes"},{"key":"R2-6-20210212","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/(SICI)1097-0029(19970601)37:5\/6<497::AID-JEMT12>3.0.CO;2-L","article-title":"Blood flow patterns in the rat pancreas: a simulative demonstration by injection replication and scanning electron microscopy.","volume":"37","author":"Murakami","year":"1997","journal-title":"Microsc Res Tech"},{"key":"R3-6-20210212","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1055\/s-0028-1093717","article-title":"Regulation of exocrine pancreatic secretory process by insulin in vivo.","volume":"7","author":"Adler","year":"1975","journal-title":"Horm Metab Res"},{"key":"R4-6-20210212","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2337\/diab.34.10.980","article-title":"The insulin-pancreatic acinar axis.","volume":"34","author":"Williams","year":"1985","journal-title":"Diabetes"},{"key":"R5-6-20210212","doi-asserted-by":"crossref","first-page":"812","DOI":"10.7326\/0003-4819-59-6-812","article-title":"External pancreatic secretion in diabetes mellitus.","volume":"59","author":"Chey","year":"1963","journal-title":"Ann Intern Med"},{"key":"R6-6-20210212","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000073655","article-title":"High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients.","volume":"3","author":"Hardt","year":"2003","journal-title":"Pancreatology"},{"key":"R7-6-20210212","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1620\/tjem.120.31","article-title":"Exocrine pancreas of streptozotocin-diabetes rats treated with insulin.","volume":"120","author":"Yagihashi","year":"1976","journal-title":"Tohoku J Exp Med"},{"key":"R8-6-20210212","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1126\/science.6166044","article-title":"Pancreatic islet-acinar cell interaction: amylase messenger RNA levels are determined by insulin.","volume":"213","author":"Korc","year":"1981","journal-title":"Science"},{"key":"R9-6-20210212","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(11)60614-4","article-title":"Type 2 diabetes across generations: from pathophysiology to prevention and management.","volume":"378","author":"Nolan","year":"2011","journal-title":"Lancet"},{"issue":"suppl 2","key":"R10-6-20210212","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.2337\/dc11-s223","article-title":"Therapy in the early stage: incretins.","volume":"34","author":"Cernea","year":"2011","journal-title":"Diabetes Care"},{"key":"R11-6-20210212","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/diacare.29.02.06.dc05-2043","article-title":"Exenatide (exendin-4)-induced pancreatitis: a case report.","volume":"29","author":"Denker","year":"2006","journal-title":"Diabetes Care"},{"key":"R12-6-20210212","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.4158\/EP10383.CR","article-title":"Vildagliptin-induced acute pancreatitis.","volume":"17","author":"Girgis","year":"2011","journal-title":"Endocr Pract"},{"key":"R13-6-20210212","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1742-1241.2010.02382.x","article-title":"Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis.","volume":"64","author":"Engel","year":"2010","journal-title":"Int J Clin Pract"},{"key":"R14-6-20210212","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2337\/db09-0058","article-title":"Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes. Interactions with metformin.","volume":"58","author":"Matveyenko","year":"2009","journal-title":"Diabetes"},{"key":"R15-6-20210212","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00125-009-1515-4","article-title":"Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas.","volume":"53","author":"Nachnani","year":"2010","journal-title":"Diabetologia"},{"key":"R16-6-20210212","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.","volume":"141","author":"Elashoff","year":"2011","journal-title":"Gastroenterology"},{"key":"R17-6-20210212","first-page":"1","article-title":"Glucagon-like peptide 1 therapy and the exocrine pancreas: innocent bystander or friendly foe Diabetologia.","volume":"53","author":"Butler","year":"2010","journal-title":""},{"issue":"suppl 1","key":"R18-6-20210212","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1331\/JAPhA.2009.09078","article-title":"Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.","volume":"49","author":"Neumiller","year":"2009","journal-title":"J Am Pharm Assoc"},{"key":"R19-6-20210212","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1463-1326.2011.01414.x","article-title":"Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans.","volume":"13","author":"Ahren","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"R20-6-20210212","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ejphar.2010.10.062","article-title":"The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats.","volume":"650","author":"Duttaroy","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"R21-6-20210212","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/en.2011-1712","article-title":"Impact of the dipeptidyl peptidase-4 inhibitor vildagliptin on glucose tolerance and -cell function and mass in insulin receptor substrate-2-knockout mice fed a high-fat diet.","volume":"153","author":"Sato","year":"2011","journal-title":"Endocrinology"},{"key":"R22-6-20210212","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejphar.2012.07.030","article-title":"Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats.","volume":"691","author":"Inaba","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"R23-6-20210212","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1242\/jcs.93.3.419","article-title":"Patterns of expression of keratin 17 in human epithelia: dependency on cell position.","volume":"93","author":"Troyanovsky","year":"1989","journal-title":"J Cell Sci"},{"key":"R24-6-20210212","first-page":"541","article-title":"Second Giessen International Workshop on Interactions of Exocrine and Endocrine Pancreatic Diseases.","volume":"9","author":"Anderen-Sandberg","year":"2008","journal-title":"JOP (Online)"},{"issue":"suppl 3","key":"R25-6-20210212","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.14309\/00000434-200910003-00237","article-title":"Abnormalities in pancreatic enzyme levels in otherwise asymptomatic subjects with type 2 diabetes.","volume":"104","author":"Bruce","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R26-6-20210212","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/gut.22.2.158","article-title":"The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland.","volume":"22","author":"Henderson","year":"1981","journal-title":"Gut"},{"key":"R27-6-20210212","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2011.12.039","article-title":"The glucagon-like peptide 1 analog liraglutide reduces TNF--induced oxidative stress and inflammation in endothelial cells.","volume":"221","author":"Shiraki","year":"2012","journal-title":"Atherosclerosis"},{"key":"R28-6-20210212","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1007\/s00125-010-1849-y","article-title":"Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients.","volume":"53","author":"Pugazhenthi","year":"2010","journal-title":"Diabetologia"},{"key":"R29-6-20210212","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1017935808074","article-title":"Impaired pancreatic duct-cell growth in focal areas of regeneration after partial pancreatectomy in the adult Goto-Kakizaki rat, a spontaneous model of non-insulin dependent diabetes mellitus.","volume":"33","author":"Plachot","year":"2001","journal-title":"Histochem J"},{"key":"R30-6-20210212","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9440(10)65596-4","article-title":"Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus.","volume":"153","author":"Koyama","year":"1998","journal-title":"Am J Pathol"},{"key":"R31-6-20210212","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2337\/diab.45.7.941","article-title":"Poor capacity for proliferation of pancreatic beta-cells in Otsuka-Long-Evans-Tokushima Fatty rat: a model of spontaneous NIDDM.","volume":"45","author":"Zhu","year":"1996","journal-title":"Diabetes"},{"key":"R32-6-20210212","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s003359900869","article-title":"A major quantitative trait locus co-localizing with cholecystokinin type A receptor gene influences poor pancreatic proliferation in a spontaneously diabetogenic rat.","volume":"9","author":"Moralejo","year":"1998","journal-title":"Mamm Genome"},{"key":"R33-6-20210212","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-009-1556-8","article-title":"Pancreatic duct replication is increased with obesity and type 2 diabetes in humans.","volume":"53","author":"Butler","year":"2010","journal-title":"Diabetologia"},{"key":"R34-6-20210212","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.2337\/db09-0626","article-title":"Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice.","volume":"58","author":"Koehler","year":"2009","journal-title":"Diabetes"},{"key":"R35-6-20210212","doi-asserted-by":"crossref","first-page":"E1076","DOI":"10.1152\/ajpendo.00479.2010","article-title":"Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents.","volume":"299","author":"Tatarkiewicz","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R36-6-20210212","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2011-0599","article-title":"The safety of incretin-based therapiesreview of the scientific evidence.","volume":"96","author":"Drucker","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-6-20210212","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2337\/db11-1109","article-title":"Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the KrasG12D mouse model.","volume":"61","author":"Gier","year":"2012","journal-title":"Diabetes"},{"key":"R38-6-20210212","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2337\/db11-0936","article-title":"The human GLP-1 analog liraglutide and the pancreas. Evidence for the absence of structural pancreatic changes in three species.","volume":"61","author":"Nyborg","year":"2012","journal-title":"Diabetes"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0b013e318287c9b5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T10:07:06Z","timestamp":1645783626000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201307000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0b013e318287c9b5","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}